SMS Pharmaceuticals Ltd

Next 500 2018
+ 1 More
+ 1 More
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Next 500 India
#463(2018)#470(2016)
#463(2018)#470(2016)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
715
(INR Cr)
Net Operating Income
709
(INR Cr)
Assets
818
(INR Cr)
Profit
50
(INR Cr)
Net Worth
536
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
715
45.6%
491
-23.0%
638
18.1%
540
25.5%
430
-10.9%
483
2.8%
469
0.2%
469
-25.0%
625
3.1%
606
19.9%
505
54.3%
328
43.1%
229
-12.9%
263
6.7%
246
-1.2%
249
-
Net Operating Income
(INR Cr)
709
35.86%
522
0.42%
520
-7.69%
563
36.71%
412
-11.39%
465
0.48%
463
5.60%
438
-28.34%
611
0.00%
587
11.77%
525
111.59%
248
14.27%
217
-5.50%
230
-1.77%
234
-3.03%
241
16.38%
Profit
(INR Cr)
50
-
-7
-
62
-0.5%
63
98.1%
32
-21.2%
40
26.1%
32
11.4%
28
-30.3%
41
16.0%
35
72.9%
20
-19.5%
25
2121.1%
1
-86.4%
8
251.1%
2
-62.1%
6
-
Assets
(INR Cr)
818
14.3%
716
-2.6%
735
10.2%
667
31.5%
507
8.5%
467
8.0%
433
6.8%
405
-19.2%
501
18.1%
424
7.0%
396
-0.9%
400
-6.9%
429
5.2%
408
8.3%
377
7.8%
349
-
Net Worth
(INR Cr)
536
16.5%
461
-2.1%
470
14.6%
411
17.9%
348
8.2%
322
13.2%
284
11.7%
255
-13.2%
294
0.0%
255
14.9%
222
-9.1%
244
10.4%
221
0.5%
220
3.1%
213
0.6%
212
1.9%
Employee Cost
(INR Cr)
57
13.4%
50
-1.8%
51
23.9%
41
4.6%
39
10.6%
36
8.5%
33
21.8%
27
-29.4%
38
20.3%
32
23.5%
26
43.5%
18
26.4%
14
7.5%
13
32.5%
10
-2.5%
10
-
Interest Cost
(INR Cr)
24221911121215161718142424181410
Cash & Bank Balance
(INR Cr)
367474110151312156123696520
Total Debt
(INR Cr)
281254263255157144146149204167167149207187163137

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues 7.0%-9.8%11.6%7.3%8.3%6.8%6.1%6.6%5.8%4.0%7.7%0.5%3.2%1.0%2.5%
Profit As % Of Assets 6.1%-8.5%9.4%6.2%8.6%7.3%7.0%8.2%8.3%5.1%6.3%0.3%2.1%0.6%1.8%
Profit As % Of Networth 9.3%-13.2%15.2%9.1%12.4%11.2%11.2%13.9%13.8%9.2%10.4%0.5%3.8%1.1%3.0%
Interest Cost to EBITDA % 20.2%40.3%16.7%9.2%15.4%13.2%16.6%21.1%19.2%20.8%24.3%-64.1%46.0%77.9%48.5%
Debt to Equity Ratio 0.520.550.560.620.450.450.510.590.700.650.750.610.940.850.770.65
RONW 9.9%-15.4%16.1%9.8%13.7%15.0%13.0%14.2%14.8%8.8%-27.8%0.5%3.9%1.1%3.0%
ROCE 11.7%3.8%12.5%17.4%13.0%16.5%18.1%12.7%14.6%20.8%11.5%-11.5%6.1%7.4%4.8%5.7%